At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
|Articles|February 11, 2022
- Pharmaceutical Commerce - February 2022
- Volume 17
- Issue 1
Pharmaceutical Commerce - February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 4 years ago
A Lowdown on Logisticsover 4 years ago
The Shifting Course in Logistics Supportover 4 years ago
How 3PLs Can Up Their Pharma Gameover 4 years ago
For Industry in Flux, is M&A Jolt in Store?over 4 years ago
CAR-T Therapies: Three Supply Chain Considerationsover 4 years ago
The Risk of Doubling Down on Pharmaover 4 years ago
Striving for Authentic, Transparent Track and Traceover 4 years ago
2022 Pharma 3PL Service Provider Directoryover 4 years ago
Booster Rollout Lessons for Pharmaalmost 5 years ago
Assessing Adoption of Hybrid DtP ModelsAdvertisement
Related to this article
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Swisslog's Mark Beers discusses how software helps pharma supply chains adapt to shifting portfolios, strengthen inventory verification and build trust.
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: PhRMA Sues to Block GLOBE Model and Bayer's $2.2B Ohio Site
2
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
3
LogiPharma USA 2026: Data Readiness Must Come Before AI
4
Pharma Rethinks Supply Chain Planning as Disruptions Mount
5